$STRR
STAR EQUITY HOLDINGS, INC. Stock $strr

$strr Overview Financials Valuation SEC Filings Company Website

2016 Q4 Form 10-Q Financial Statement

#000070738816000084 Filed on October 31, 2016

Income Statement

Concept	2016 Q4	2016 Q3	2015 Q4
Revenue	$31.13M	$31.09M	$15.58M
YoY Change	99.86%	95.98%	10.15%
Cost Of Revenue	$22.49M	$22.79M	$10.89M
YoY Change	106.52%	106.01%	10.45%
Gross Profit	$8.642M	$8.301M	$4.692M
YoY Change	84.19%	72.87%	9.52%
Gross Profit Margin	27.76%	26.7%	30.12%
Selling, General & Admin	$6.250M	$7.034M	$4.060M
YoY Change	53.94%	89.09%	21.56%
% of Gross Profit	72.32%	84.74%	86.53%
Research & Development			$0.00
YoY Change
% of Gross Profit			0.0%
Depreciation & Amortization	$2.550M	$2.490M	$700.0K
YoY Change	264.29%	274.44%	40.0%
% of Gross Profit	29.51%	30.0%	14.92%
Operating Expenses	$6.830M	$7.612M	$4.190M
YoY Change	63.01%	97.51%	21.8%
Operating Profit	$1.477M	$689.0K	$498.0K
YoY Change	196.59%	-27.32%	-38.97%
Interest Expense	-$320.0K	$342.0K	-$250.0K
YoY Change	28.0%	3009.09%
% of Operating Profit	-21.67%	49.64%	-50.2%
Other Income/Expense, Net	$630.0K	-$770.0K
YoY Change		6900.0%
Pretax Income	$1.780M	-$81.00K	$250.0K
YoY Change	612.0%	-108.64%	-69.51%
Income Tax	-$200.0K	$202.0K	-$430.0K
% Of Pretax Income	-11.24%		-172.0%
Net Earnings	$1.978M	-$283.0K	$678.0K
YoY Change	191.74%	-101.48%	-12.18%
Net Earnings / Revenue	6.35%	-0.91%	4.35%
Basic Earnings Per Share	$0.10	-$0.01	$0.03
Diluted Earnings Per Share	$0.10	-$0.01	$0.03
COMMON SHARES
Basic Shares Outstanding	19.68M shares	19.62M shares	19.42M shares
Diluted Shares Outstanding		19.62M shares

Balance Sheet

Concept	2016 Q4	2016 Q3	2015 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$3.100M	$3.700M	$19.10M
YoY Change	-83.77%	-81.41%	-13.18%
Cash & Equivalents	$2.203M	$2.353M	$15.87M
Short-Term Investments	$900.0K	$1.300M	$3.200M
Other Short-Term Assets	$2.093M	$233.0K	$764.0K
YoY Change	173.95%	-88.31%	-10.75%
Inventory	$5.987M	$5.909M	$4.381M
Prepaid Expenses
Receivables	$14.50M	$13.64M	$7.274M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$27.08M	$27.09M	$31.75M
YoY Change	-14.7%	-22.02%	-3.66%
LONG-TERM ASSETS
Property, Plant & Equipment	$31.41M	$31.12M	$6.252M
YoY Change	402.35%	370.5%	31.18%
Goodwill	$6.237M	$6.819M	$2.897M
YoY Change	115.29%	135.38%	116.68%
Intangibles	$11.63M	$12.21M	$3.079M
YoY Change	277.66%	279.89%	19.48%
Long-Term Investments
YoY Change
Other Assets	$793.0K	$903.0K	$1.560M
YoY Change	-49.17%	-30.43%	479.93%
Total Long-Term Assets	$79.18M	$79.99M	$32.37M
YoY Change	144.65%	159.6%	261.67%
TOTAL ASSETS
Total Short-Term Assets	$27.08M	$27.09M	$31.75M
Total Long-Term Assets	$79.18M	$79.99M	$32.37M
Total Assets	$106.3M	$107.1M	$64.11M
YoY Change	65.74%	63.35%	53.01%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$6.514M	$6.466M	$1.369M
YoY Change	375.82%	131.18%	-3.79%
Accrued Expenses	$4.200M	$4.400M	$3.500M
YoY Change	20.0%	41.94%	2.94%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$5.358M	$5.358M	$0.00
YoY Change
Total Short-Term Liabilities	$22.67M	$23.76M	$8.706M
YoY Change	160.43%	139.93%	4.98%
LONG-TERM LIABILITIES
Long-Term Debt	$16.07M	$17.34M	$0.00
YoY Change
Other Long-Term Liabilities	$1.039M	$1.163M	$1.252M
YoY Change	-17.01%	-12.36%	30.01%
Total Long-Term Liabilities	$17.11M	$18.50M	$1.252M
YoY Change	1266.53%	1294.35%	30.01%
TOTAL LIABILITIES
Total Short-Term Liabilities	$22.67M	$23.76M	$8.706M
Total Long-Term Liabilities	$17.11M	$18.50M	$1.252M
Total Liabilities	$39.78M	$42.27M	$9.958M
YoY Change	299.5%	276.33%	7.58%
SHAREHOLDERS EQUITY
Retained Earnings	-$79.44M	-$81.42M	-$93.74M
YoY Change	-15.26%	-13.77%	-18.76%
Common Stock	$2.000K	$2.000K	$2.000K
YoY Change	0.0%	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$5.728M	$5.728M	$5.728M
YoY Change	0.0%	0.0%	0.0%
Treasury Stock Shares	2.588M shares	2.588M shares	2.588M shares
Shareholders Equity	$66.48M	$64.82M	$54.16M
YoY Change
Total Liabilities & Shareholders Equity	$106.3M	$107.1M	$64.11M
YoY Change	65.74%	63.35%	53.01%

Cashflow Statement

Concept	2016 Q4	2016 Q3	2015 Q4
OPERATING ACTIVITIES
Net Income	$1.978M	-$283.0K	$678.0K
YoY Change	191.74%	-101.48%	-12.18%
Depreciation, Depletion And Amortization	$2.550M	$2.490M	$700.0K
YoY Change	264.29%	274.44%	40.0%
Cash From Operating Activities	$4.010M	$3.020M	$750.0K
YoY Change	434.67%	319.44%	-42.31%
INVESTING ACTIVITIES
Capital Expenditures	-$2.230M	-$1.000M	-$240.0K
YoY Change	829.17%	233.33%	118.18%
Acquisitions
YoY Change
Other Investing Activities	$490.0K	$950.0K	$2.730M
YoY Change	-82.05%	-513.04%	155.14%
Cash From Investing Activities	-$1.730M	-$50.00K	$2.490M
YoY Change	-169.48%	-90.57%	159.38%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-2.440M	-3.900M	-1.270M
YoY Change	92.13%	230.51%	28.28%
NET CHANGE
Cash From Operating Activities	4.010M	3.020M	750.0K
Cash From Investing Activities	-1.730M	-50.00K	2.490M
Cash From Financing Activities	-2.440M	-3.900M	-1.270M
Net Change In Cash	-160.0K	-930.0K	1.970M
YoY Change	-108.12%	-6.06%	55.12%
FREE CASH FLOW
Cash From Operating Activities	$4.010M	$3.020M	$750.0K
Capital Expenditures	-$2.230M	-$1.000M	-$240.0K
Free Cash Flow	$6.240M	$4.020M	$990.0K
YoY Change	530.3%	294.12%	-29.79%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2016
CY2015Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	175000	USD
CY2016Q3	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	140000	USD
	dei	Document Period End Date DocumentPeriodEndDate	2016-09-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0000707388
CY2016Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	19679640	shares
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	DIGIRAD CORP
CY2016Q3	digirad	Capital Leases Future Minimum Payments Duein Six Years CapitalLeasesFutureMinimumPaymentsDueinSixYears	0	USD
	digirad	Effectof Depreciation EffectofDepreciation	100000	USD
CY2016Q3	digirad	Finite Lived Intangible Assets Amortization Expense Year Six FiniteLivedIntangibleAssetsAmortizationExpenseYearSix	1500000	USD
CY2015Q3	digirad	Incremental Common Shares Attributable To Restricted Stock Units IncrementalCommonSharesAttributableToRestrictedStockUnits	24000	shares
	digirad	Incremental Common Shares Attributable To Restricted Stock Units IncrementalCommonSharesAttributableToRestrictedStockUnits	19000	shares
CY2016Q3	digirad	Incremental Common Shares Attributable To Restricted Stock Units IncrementalCommonSharesAttributableToRestrictedStockUnits	0	shares
	digirad	Incremental Common Shares Attributable To Restricted Stock Units IncrementalCommonSharesAttributableToRestrictedStockUnits	75000	shares
	digirad	Line Of Credit Facility Prepayment Fee LineOfCreditFacilityPrepaymentFee	0.01
CY2016Q3	digirad	Operating Leases Future Minimum Payments Duein Six Years OperatingLeasesFutureMinimumPaymentsDueinSixYears	201000	USD
CY2015Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1369000	USD
CY2016Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	6466000	USD
CY2015Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	7274000	USD
CY2016Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	13637000	USD
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-96000	USD
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-28000	USD
CY2015Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	23140000	USD
CY2016Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	26775000	USD
CY2015Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-240000	USD
CY2016Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	0	USD
CY2015Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	153860000	USD
CY2016Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	151961000	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	0	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	280000	USD
CY2015Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	134000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	372000	USD
CY2016Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	578000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1735000	USD
CY2015Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2000	shares
CY2016Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	491000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	14000	shares
CY2015Q4	us-gaap	Assets Assets	64113000	USD
CY2016Q3	us-gaap	Assets Assets	107086000	USD
CY2015Q4	us-gaap	Assets Current AssetsCurrent	31747000	USD
CY2016Q3	us-gaap	Assets Current AssetsCurrent	27094000	USD
CY2015Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	3718000	USD
CY2015Q4	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	3227000	USD
CY2016Q3	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	1313000	USD
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-27000	USD
	us-gaap	Business Combination Contingent Consideration Arrangements Change In The Range Of Outcomes Contingent Consideration Liability Value High BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh	-8000	USD
	us-gaap	Business Combination Provisional Information Initial Accounting Incomplete Adjustment Financial Liabilities BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancialLiabilities	15000	USD
	us-gaap	Business Combination Provisional Information Initial Accounting Incomplete Adjustment Property Plant And Equipment BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment	-200000	USD
	us-gaap	Business Combination Provisional Information Initial Accounting Incomplete Adjustments Related To Previous Period BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod	600000	USD
CY2016Q3	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	675000	USD
CY2016Q3	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	573000	USD
CY2016Q3	us-gaap	Capital Leases Future Minimum Payments Due CapitalLeasesFutureMinimumPaymentsDue	1321000	USD
CY2016Q3	us-gaap	Capital Leases Future Minimum Payments Due In Five Years CapitalLeasesFutureMinimumPaymentsDueInFiveYears	29000	USD
CY2016Q3	us-gaap	Capital Leases Future Minimum Payments Due In Four Years CapitalLeasesFutureMinimumPaymentsDueInFourYears	122000	USD
CY2016Q3	us-gaap	Capital Leases Future Minimum Payments Due In Three Years CapitalLeasesFutureMinimumPaymentsDueInThreeYears	308000	USD
CY2016Q3	us-gaap	Capital Leases Future Minimum Payments Due In Two Years CapitalLeasesFutureMinimumPaymentsDueInTwoYears	665000	USD
CY2016Q3	us-gaap	Capital Leases Future Minimum Payments Due Thereafter CapitalLeasesFutureMinimumPaymentsDueThereafter	0	USD
CY2016Q3	us-gaap	Capital Leases Future Minimum Payments Interest Included In Payments CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments	73000	USD
CY2016Q3	us-gaap	Capital Leases Future Minimum Payments Present Value Of Net Minimum Payments CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments	1248000	USD
CY2016Q3	us-gaap	Capital Leases Future Minimum Payments Remainder Of Fiscal Year CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear	197000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14051000	USD
CY2015Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13895000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	15868000	USD
CY2016Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2353000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-156000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-13515000	USD
CY2015Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2015Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.05
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.15
CY2016Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.05
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.15
CY2015Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2016Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2015Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	80000000	shares
CY2016Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	80000000	shares
CY2015Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	19416070	shares
CY2016Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	19679640	shares
CY2015Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	19416070	shares
CY2016Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	19679640	shares
CY2015Q4	us-gaap	Common Stock Value CommonStockValue	2000	USD
CY2016Q3	us-gaap	Common Stock Value CommonStockValue	2000	USD
CY2015Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	19123000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	20978000	USD
CY2016Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-20000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	12564000	USD
CY2015Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	11060000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	32032000	USD
CY2016Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	22785000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	67202000	USD
CY2015Q3	us-gaap	Cost Of Goods Sold CostOfGoodsSold	1859000	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	5112000	USD
CY2016Q3	us-gaap	Cost Of Goods Sold CostOfGoodsSold	3675000	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	10407000	USD
CY2015Q3	us-gaap	Cost Of Services CostOfServices	9201000	USD
	us-gaap	Cost Of Services CostOfServices	26920000	USD
CY2016Q3	us-gaap	Cost Of Services CostOfServices	19110000	USD
	us-gaap	Cost Of Services CostOfServices	56795000	USD
CY2016Q3	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	605000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-12100000	USD
CY2015Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	1673000	USD
CY2016Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	3317000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Liabilities Net Noncurrent DeferredTaxAssetsLiabilitiesNetNoncurrent	18578000	USD
CY2016Q3	us-gaap	Deferred Tax Assets Liabilities Net Noncurrent DeferredTaxAssetsLiabilitiesNetNoncurrent	26100000	USD
CY2016Q3	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	900000	USD
	us-gaap	Depreciation Depreciation	1379000	USD
	us-gaap	Depreciation Depreciation	5602000	USD
CY2015Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.99
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.09
CY2016Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.63
CY2015Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.97
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.07
CY2016Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.62
CY2015Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2453000	USD
CY2016Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	4232000	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	3589000	USD
CY2016Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	5324000	USD
CY2016Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	2300000	USD
CY2016Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	600000	USD
CY2016Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	1500000	USD
CY2016Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	1800000	USD
CY2016Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	2200000	USD
CY2016Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	2300000	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	6668000	USD
CY2016Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	17530000	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	3079000	USD
CY2016Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	12206000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-9000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	14000	USD
CY2015Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2508000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6880000	USD
CY2016Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4608000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	15900000	USD
CY2015Q4	us-gaap	Goodwill Goodwill	2897000	USD
CY2016Q3	us-gaap	Goodwill Goodwill	6819000	USD
CY2015Q4	us-gaap	Goodwill Gross GoodwillGross	2897000	USD
CY2016Q3	us-gaap	Goodwill Gross GoodwillGross	6819000	USD
	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	-385000	USD
CY2015Q3	us-gaap	Gross Profit GrossProfit	4802000	USD
	us-gaap	Gross Profit GrossProfit	13217000	USD
CY2016Q3	us-gaap	Gross Profit GrossProfit	8301000	USD
	us-gaap	Gross Profit GrossProfit	27131000	USD
CY2015Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	937000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2264000	USD
CY2016Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-81000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	102000	USD
CY2015Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-18183000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-18698000	USD
CY2016Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	202000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-12222000	USD
	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	13000000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1167000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	431000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2171000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	201000	USD
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	18167000	USD
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	11806000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-166000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-148000	USD
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-470000	USD
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-830000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	730000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1331000	USD
	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-399000	USD
	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-719000	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-227000	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	227000	USD
	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	0	USD
	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	2745000	USD
	us-gaap	Increase Decrease In Restricted Cash For Operating Activities IncreaseDecreaseInRestrictedCashForOperatingActivities	-244000	USD
	us-gaap	Increase Decrease In Restricted Cash For Operating Activities IncreaseDecreaseInRestrictedCashForOperatingActivities	0	USD
CY2015Q3	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	418000	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	444000	shares
CY2016Q3	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	419000	shares
CY2015Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3079000	USD
CY2016Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	12206000	USD
CY2015Q3	us-gaap	Interest Expense InterestExpense	11000	USD
	us-gaap	Interest Expense InterestExpense	12000	USD
CY2016Q3	us-gaap	Interest Expense InterestExpense	342000	USD
	us-gaap	Interest Expense InterestExpense	1092000	USD
CY2016Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	300000	USD
	us-gaap	Interest Expense Debt InterestExpenseDebt	1100000	USD
CY2015Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	851000	USD
CY2016Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	2031000	USD
CY2015Q4	us-gaap	Inventory Gross InventoryGross	5100000	USD
CY2016Q3	us-gaap	Inventory Gross InventoryGross	6350000	USD
CY2015Q4	us-gaap	Inventory Net InventoryNet	4381000	USD
CY2016Q3	us-gaap	Inventory Net InventoryNet	5909000	USD
CY2015Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	2600000	USD
CY2016Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	2872000	USD
CY2015Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	719000	USD
CY2016Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	441000	USD
CY2015Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	1649000	USD
CY2016Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	1447000	USD
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	900000	USD
CY2015Q4	us-gaap	Liabilities Liabilities	9958000	USD
CY2016Q3	us-gaap	Liabilities Liabilities	42266000	USD
CY2015Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	64113000	USD
CY2016Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	107086000	USD
CY2015Q4	us-gaap	Liabilities Current LiabilitiesCurrent	8706000	USD
CY2016Q3	us-gaap	Liabilities Current LiabilitiesCurrent	23763000	USD
CY2016Q3	us-gaap	Line Of Credit Facility Current Borrowing Capacity LineOfCreditFacilityCurrentBorrowingCapacity	5300000	USD
	us-gaap	Line Of Credit Facility Expiration Period LineOfCreditFacilityExpirationPeriod	P5Y
CY2016Q1	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	40000000.0	USD
	us-gaap	Line Of Credit Facility Unused Capacity Commitment Fee Percentage LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage	0.0025
CY2016Q3	us-gaap	Long Term Debt LongTermDebt	23303000	USD
CY2015Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	0	USD
CY2016Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	5358000	USD
CY2016Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	5958000	USD
CY2016Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	1340000	USD
CY2016Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	2856000	USD
CY2016Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	2856000	USD
CY2016Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	4935000	USD
CY2016Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	5358000	USD
CY2016Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	17340000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2830000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	7046000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-291000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-27377000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2965000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	6816000	USD
CY2015Q3	us-gaap	Net Income Loss NetIncomeLoss	19120000	USD
	us-gaap	Net Income Loss NetIncomeLoss	20962000	USD
CY2016Q3	us-gaap	Net Income Loss NetIncomeLoss	-283000	USD
	us-gaap	Net Income Loss NetIncomeLoss	12324000	USD
	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	1340000	USD
	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	269000	USD
CY2015Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-11000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-12000	USD
CY2016Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-770000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1506000	USD
CY2015Q4	us-gaap	Notes Payable To Bank Noncurrent NotesPayableToBankNoncurrent	0	USD
CY2016Q3	us-gaap	Notes Payable To Bank Noncurrent NotesPayableToBankNoncurrent	17340000	USD
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	4	segment
CY2015Q3	us-gaap	Operating Expenses OperatingExpenses	3854000	USD
	us-gaap	Operating Expenses OperatingExpenses	10941000	USD
CY2016Q3	us-gaap	Operating Expenses OperatingExpenses	7612000	USD
	us-gaap	Operating Expenses OperatingExpenses	25523000	USD
CY2015Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	948000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	2276000	USD
CY2016Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	689000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	1608000	USD
CY2016Q3	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	5383000	USD
CY2016Q3	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	636000	USD
CY2016Q3	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	846000	USD
CY2016Q3	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	1053000	USD
CY2016Q3	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	1361000	USD
CY2016Q3	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	0	USD
CY2016Q3	us-gaap	Operating Leases Future Minimum Payments Remainder Of Fiscal Year OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear	1286000	USD
CY2015Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2998000	USD
CY2016Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	4237000	USD
CY2015Q4	us-gaap	Other Assets Current OtherAssetsCurrent	233000	USD
CY2016Q3	us-gaap	Other Assets Current OtherAssetsCurrent	233000	USD
CY2015Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1560000	USD
CY2016Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	903000	USD
CY2015Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	3000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	16000	USD
CY2016Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	263000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	240000	USD
CY2015Q3	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Writedown Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForWritedownOfSecuritiesBeforeTax	0	USD
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Writedown Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForWritedownOfSecuritiesBeforeTax	0	USD
CY2016Q3	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Writedown Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForWritedownOfSecuritiesBeforeTax	263000	USD
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Writedown Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForWritedownOfSecuritiesBeforeTax	230000	USD
CY2015Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	3000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	16000	USD
CY2016Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	0	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	10000	USD
CY2015Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1252000	USD
CY2016Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1163000	USD
CY2015Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	USD
CY2016Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-428000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-414000	USD
	us-gaap	Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet	0	USD
	us-gaap	Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet	413000	USD
CY2016Q3	us-gaap	Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNetAvailableforsaleSecurities	400000	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	504000	USD
	us-gaap	Payments Of Dividends PaymentsOfDividends	2862000	USD
	us-gaap	Payments Of Dividends PaymentsOfDividends	2927000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	97000	USD
	us-gaap	Payments To Acquire Available For Sale Securities Equity PaymentsToAcquireAvailableForSaleSecuritiesEquity	1000000	USD
	us-gaap	Payments To Acquire Available For Sale Securities Equity PaymentsToAcquireAvailableForSaleSecuritiesEquity	0	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	-3000	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	25482000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1181000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3962000	USD
CY2015Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2016Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2015Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2016Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2015Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2016Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2015Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2016Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2015Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2016Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	432000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	371000	USD
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	USD
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	34257000	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	0	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-27000	USD
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	1869000	USD
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	1896000	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	18000	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	171000	USD
CY2015Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	213000	USD
CY2016Q3	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	153000	USD
CY2015Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	29392000	USD
CY2016Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	57894000	USD
CY2015Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6252000	USD
CY2016Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	31119000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	162000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	525000	USD
	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	400000	USD
	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	577000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	20705000	USD
CY2015Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	764000	USD
CY2016Q3	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	3649000	USD
CY2015Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	0	USD
CY2016Q3	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	2845000	USD
CY2016Q3	us-gaap	Restricted Cash And Investments Noncurrent RestrictedCashAndInvestmentsNoncurrent	4000000	USD
CY2015Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-93739000	USD
CY2016Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-81415000	USD
CY2015Q3	us-gaap	Revenues Revenues	15862000	USD
	us-gaap	Revenues Revenues	45249000	USD
CY2016Q3	us-gaap	Revenues Revenues	31086000	USD
	us-gaap	Revenues Revenues	94333000	USD
CY2015Q3	us-gaap	Sales Revenue Goods Gross SalesRevenueGoodsGross	15862000	USD
	us-gaap	Sales Revenue Goods Gross SalesRevenueGoodsGross	45249000	USD
CY2016Q3	us-gaap	Sales Revenue Goods Gross SalesRevenueGoodsGross	31086000	USD
	us-gaap	Sales Revenue Goods Gross SalesRevenueGoodsGross	94333000	USD
CY2015Q3	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	3880000	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	10525000	USD
CY2016Q3	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	7261000	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	21837000	USD
CY2015Q3	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	11982000	USD
	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	34724000	USD
CY2016Q3	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	23825000	USD
	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	72496000	USD
CY2015Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1212000	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	3689000	USD
CY2016Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2426000	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	7888000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	450000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	754000	USD
	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	2684000	USD
	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	0	USD
CY2015Q4	us-gaap	Stockholders Equity StockholdersEquity	54155000	USD
CY2016Q3	us-gaap	Stockholders Equity StockholdersEquity	64820000	USD
CY2015Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	2588484	shares
CY2016Q3	us-gaap	Treasury Stock Shares TreasuryStockShares	2588484	shares
CY2015Q4	us-gaap	Treasury Stock Value TreasuryStockValue	5728000	USD
CY2016Q3	us-gaap	Treasury Stock Value TreasuryStockValue	5728000	USD
CY2016Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	4100000	USD
CY2016Q3	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	3400000	USD
CY2015Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19798000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19608000	shares
CY2016Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19618000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20026000	shares
CY2015Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19356000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19145000	shares
CY2016Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19618000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19532000	shares
	us-gaap	Nature Of Operations NatureOfOperations	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">The Company</font></div><div style="line-height:120%;padding-top:6px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Digirad delivers convenient, effective, and efficient healthcare solutions on an as needed, when needed, and where needed basis. Digirad's diverse portfolio of mobile healthcare solutions and medical equipment and services, including diagnostic imaging and patient monitoring, provides hospitals, physician practices, and imaging centers throughout the United States access to technology and services necessary to provide exceptional patient care in the rapidly changing healthcare environment.</font></div><div style="line-height:120%;padding-top:6px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On January 1, 2016, we acquired Project Rendezvous Holding Corporation, the holding company of DMS Health Technologies. DMS Health Technologies (“DMS Health”) offers mobile diagnostic imaging across multiple imaging modalities, including Positron Emission Tomography (“PET”), Computed Tomography (“CT”), Magnetic Resonance Imaging (“MRI”) as well as other imaging and healthcare services. These services are provided to regional and rural hospitals and institutions throughout the United States. In addition, DMS Health, through an exclusive relationship with Philips Healthcare, sells and services Philips' imaging and patient monitoring equipment within a defined region of the upper Midwest region of the United States. </font></div><div style="line-height:120%;padding-top:6px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">With the acquisition of DMS Health, we now operate the Company in </font><font style="font-family:inherit;font-size:10pt;">four</font><font style="font-family:inherit;font-size:10pt;"> reportable segments:</font></div><div style="line-height:120%;padding-left:24px;padding-top:6px;text-align:justify;"><font style="padding-top:6px;text-align:justify;font-family:inherit;font-size:10pt;padding-right:24px;">1.</font><font style="font-family:inherit;font-size:10pt;">Diagnostic Services</font></div><div style="line-height:120%;padding-left:24px;text-align:justify;"><font style="text-align:justify;font-family:inherit;font-size:10pt;padding-right:24px;">2.</font><font style="font-family:inherit;font-size:10pt;">Diagnostic Imaging</font></div><div style="line-height:120%;padding-left:24px;text-align:justify;"><font style="text-align:justify;font-family:inherit;font-size:10pt;padding-right:24px;">3.</font><font style="font-family:inherit;font-size:10pt;">Mobile Healthcare</font></div><div style="line-height:120%;padding-left:24px;text-align:justify;"><font style="text-align:justify;font-family:inherit;font-size:10pt;padding-right:24px;">4.</font><font style="font-family:inherit;font-size:10pt;">Medical Device Sales and Service</font></div><div style="line-height:120%;padding-top:6px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">These four reportable segments are collectively referred to herein as the “Company.” See Note 11 to the unaudited condensed consolidated financial statements for more information related to the Company's segments. The accompanying condensed consolidated financial statements include the operations of all reportable segments. Intercompany accounts and transactions are accounted for at cost and have been eliminated in consolidation. All our long-lived assets are located in the United States and substantially all of our revenues arise from sales in the United States. </font></div><div style="line-height:120%;padding-top:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Basis of Presentation</font></div><div style="line-height:120%;padding-top:6px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The unaudited condensed consolidated financial statements included in this Form 10-Q have been prepared in accordance with the U.S. Securities and Exchange Commission ("SEC") instructions for Quarterly Reports on Form 10-Q. Accordingly, the condensed consolidated financial statements are unaudited and do not contain all the information required by U.S. generally accepted accounting principles ("GAAP") to be included in a full set of financial statements. The unaudited condensed consolidated balance sheet at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2015</font><font style="font-family:inherit;font-size:10pt;"> has been derived from the audited consolidated financial statements at that date but does not include all of the information and footnotes required by GAAP for a complete set of financial statements. The audited consolidated financial statements for our fiscal year ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2015</font><font style="font-family:inherit;font-size:10pt;">, filed with the SEC on Form 10-K on March 1, 2016, include a summary of our significant accounting policies and should be read in conjunction with this Form 10-Q. In the opinion of management, all material adjustments necessary to present fairly the results of operations, cash flows, and balance sheets for such periods have been included in this Form 10-Q. All such adjustments are of a normal recurring nature. The results of operations for interim periods are not necessarily indicative of the results of operations for the entire year. </font></div><div style="line-height:120%;padding-top:6px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Preparation of financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities, and the reported amounts of revenues and expenses. By their nature, estimates are subject to an inherent degree of uncertainty. Actual results could differ from management’s estimates.</font></div><div style="line-height:120%;padding-top:6px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The financial results for the three and nine months ended </font><font style="font-family:inherit;font-size:10pt;">September 30, 2016</font><font style="font-family:inherit;font-size:10pt;"> include the financial results of DMS Health. See Note 3 to the unaudited condensed consolidated financial statements for more information related to the acquisition of DMS Health.</font></div><div style="line-height:120%;padding-top:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Recent Accounting Pronouncements</font></div><div style="line-height:120%;padding-top:6px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In August 2016, the Financial Accounting Standards Board (the "FASB") issued new guidance related to the classification of certain cash receipts and cash payments on the statement of cash flows. The pronouncement provides clarification guidance on eight specific cash flow presentation issues that have developed due to diversity in practice. The issues include, but are not limited to, debt prepayment or extinguishment costs, settlement of zero-coupon debt, proceeds from the settlement of insurance claims, and cash receipts from payments on beneficial interests in securitization transactions. The pronouncement is effective for fiscal years, and for interim periods within those fiscal years, beginning after December 15, 2017, with early adoption permitted. We are currently evaluating the impact, if any, of adopting this guidance on our financial statements. </font></div><div style="line-height:120%;padding-top:6px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In June 2016, the FASB issued new guidance that changes the accounting for recognizing impairments of financial assets. Under the new guidance, credit losses for certain types of financial instruments will be estimated based on expected losses. The new guidance also modifies the impairment models for available-for-sale debt securities and for purchased financial assets with credit deterioration since their origination. This guidance will be effective for annual and interim periods beginning after December 15, 2019 with early adoption permitted beginning for periods after December 15, 2018. We are currently evaluating the impact of the guidance on our financial statements. </font></div><div style="line-height:120%;padding-top:6px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In March 2016, the FASB amended the existing accounting standards for how companies account for certain aspects of share-based payment awards to employees, including the accounting for income taxes, forfeitures, and statutory tax withholding requirements, as well as classification in the statement of cash flows. This update is effective for annual and interim periods beginning after December 15, 2016. This guidance will be applied either prospectively, retrospectively, or using a modified retrospective transition method, depending on the area covered in this update. Early adoption is permitted. We are currently evaluating the alternative transition methods and the potential effects of the adoption of this guidance on our financial statements.</font></div><div style="line-height:120%;padding-top:6px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2016, the FASB amended the existing accounting standards for the accounting for leases. The amendments are based on the principle that assets and liabilities arising from leases should be recognized within the financial statements. The Company is required to adopt the amendments beginning in 2019. Early adoption is permitted. The amendments must be applied using a modified retrospective transition approach and the FASB decided not to permit a full retrospective transition approach. We are currently evaluating the impact these amendments will have on our consolidated financial statements. </font></div><div style="line-height:120%;padding-top:6px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In January 2016, the FASB amended the existing accounting standards for the accounting for financial instruments. The amendments require equity investments, with certain exceptions, to be measured at fair value with changes in fair value recognized in net income. The new standard is effective prospectively for fiscal years beginning after December 15, 2017. We are currently evaluating the impact, if any, of adopting this guidance on our financial statements. </font></div><div style="line-height:120%;padding-top:6px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In September 2015, the FASB issued guidance which eliminates the requirement for an acquirer to retrospectively adjust provisional amounts recorded in a business combination to reflect new information about the facts and circumstances that existed as of the acquisition date and that, if known, would have affected measurement or recognition of amounts initially recognized. As an alternative, the amendment requires that an acquirer recognize adjustments to provisional amounts that are identified during the measurement period in the reporting period in which the adjustment amounts are determined. The amendments require that the acquirer record, in the financial statements of the period in which adjustments to provisional amounts are determined, the effect on earnings of changes in depreciation, amortization, or other income effects, if any, as a result of the change to the provisional amounts, calculated as if the accounting had been completed at the acquisition date. The new standard is effective prospectively for fiscal years beginning after December 15, 2015, including interim periods within those fiscal years. We adopted this standard in the first quarter of 2016 and this guidance was applied to the manner in which adjustments to provisional amounts in the DMS Health acquisition have been recognized (See Note 3).</font></div><div style="line-height:120%;padding-top:6px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In July 2015, the FASB issued guidance that amends the guidelines for the measurement of inventory from lower of cost or market to the lower of cost and net realizable value ("NRV"). NRV is defined as the estimated selling prices in the ordinary course of business less reasonably predictable costs of completion, disposal, and transportation. Under existing standards, inventory is measured at lower of cost or market, which requires the consideration of replacement cost, NRV, and NRV less an amount that approximates a normal profit margin. This ASU eliminates the requirement to determine and consider replacement cost or NRV less an approximately normal profit margin for inventory measurement. The new standard is effective prospectively for fiscal years beginning after December 15, 2016. We are currently evaluating the impact, if any, of adopting this guidance on our financial statements. </font></div><div style="line-height:120%;padding-top:6px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In April 2015, the FASB issued guidance that requires debt issuance costs to be presented in the balance sheet as a direct deduction from the debt liability rather than as an asset. The update requires retrospective application and represents a change in accounting principle. The guidance does not specifically address requirements for the presentation or subsequent measurement of debt issuance costs related to line-of-credit arrangements. In August 2015, the FASB issued guidance clarifying that debt issuance costs related to line-of-credit arrangements could be presented as an asset and amortized over the term of the line-of-credit arrangement, regardless of whether there are any outstanding borrowings on the line-of-credit arrangement. The standard is effective for annual periods beginning after December 15, 2015, including interim periods within those fiscal years. We adopted this guidance in the first quarter of 2016 for the presentation of our debt issuance costs incurred in connection with our new credit facility entered into on January 1, 2016 (See Note 8). </font></div><div style="line-height:120%;padding-top:6px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In May 2014, the FASB issued guidance that outlines a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers which supersedes most current revenue recognition guidance, including industry-specific guidance. The guidance provides that an entity recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. This guidance also requires additional disclosure about the nature, amount, timing, and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments, and assets recognized from costs incurred to obtain or fulfill a contract. The guidance allows for either full retrospective or modified retrospective adoption and is currently scheduled to become effective for us in the first quarter of 2018. We are currently evaluating the alternative transition methods and the potential effects of the adoption of this guidance on our financial statements.</font></div></div>

Files In Submission

Name	View Source	Status
0000707388-16-000084-index-headers.html	Edgar Link	pending
0000707388-16-000084-index.html	Edgar Link	pending
0000707388-16-000084.txt	Edgar Link	pending
0000707388-16-000084-xbrl.zip	Edgar Link	pending
a1a07.jpg	Edgar Link	pending
digirad-20160930.xml	Edgar Link	completed
digirad-20160930.xsd	Edgar Link	pending
digirad-20160930_cal.xml	Edgar Link	unprocessable
digirad-20160930_def.xml	Edgar Link	unprocessable
digirad-20160930_lab.xml	Edgar Link	unprocessable
digirad-20160930_pre.xml	Edgar Link	unprocessable
drad-9302016x10q.htm	Edgar Link	pending
drad-9302016xex311.htm	Edgar Link	pending
drad-9302016xex312.htm	Edgar Link	pending
drad-9302016xex321.htm	Edgar Link	pending
drad-9302016xex322.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$STRR
STAR EQUITY HOLDINGS, INC. Stock $strr

2016 Q4 Form 10-Q Financial Statement

#000070738816000084 Filed on October 31, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$STRR STAR EQUITY HOLDINGS, INC. Stock $strr

2016 Q4 Form 10-Q Financial Statement

#000070738816000084 Filed on October 31, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$STRR
STAR EQUITY HOLDINGS, INC. Stock $strr